Tuberculosis in transplant recipients: Diagnostic and therapeutic dilemmas

Transplant Infectious Disease

Volumn 10, Issue 4, 2008, Pages 229-230

  Subramanian, A K ^a   Nuermberger, E L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; AMIKACIN; ANTIBODY; CALCINEURIN INHIBITOR; CAPREOMYCIN; ISONIAZID; KANAMYCIN; OKT 3; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; RIFAMYCIN; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANTIBIOTIC RESISTANCE; EDITORIAL; EXTRAPULMONARY TUBERCULOSIS; GRAFT RECIPIENT; GRAFT REJECTION; GRANULOMATOSIS; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; LIVER TOXICITY; LUNG TUBERCULOSIS; MORTALITY; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; MYCOSIS; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; GASTROINTESTINAL HEMORRHAGE; HUMANS; KIDNEY TRANSPLANTATION; ORGAN TRANSPLANTATION; TUBERCULOSIS; TUBERCULOSIS, GASTROINTESTINAL; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 47849084048     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2008.00332.x     Document Type: Editorial

References (12)

1. Munoz P, Rodriguez C, Bouza E. Mycobacterium tuberculosis infection in recipients of solid organ transplants. Clin Infect Dis 2005 40 : 581 587.
2. Ginsburg AM, Spigelman M. Challenges in tuberculosis drug research and development. Nat Med 2007 13 : 290 294.
3. Singh N, Paterson DL. Mycobacterium tuberculosis infection in solid organ transplant recipients: impact and implications for management. Clin Infect Dis 1998 27 : 1266 1277.
4. Siu YP Tong MKH, Kwok YL, et al. An unusual case of both upper and lower gastrointestinal bleeding in a kidney transplant recipient. Transpl Infect Dis 2008 10 : 276 279.
5. Basiri A, Hosseini-Moghaddam SM, Simforoosh N, et al. The risk factors and laboratory diagnostics for post renal transplant tuberculosis: a case-control, country-wide study on definitive cases. Transpl Infect Dis 2008 10 : 231 235.
6. Wallis RS, Broder MS, Wong JY, Hanson ME, Beenhouwer DO. Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis 2004 38 : 1261 1265.
7. Walsh R, Ortiz J, Foster P, Palma-Varga J, Rosenblatt S, Wright F. Fungal and mycobacterial infections after Campath (alemtuzumab) induction for renal transplantation. Transpl Infect Dis 2008 10 : 236 239.
8. Nash KL, Yeung TM, Lehner PJ, Gibbs P, Griffiths WJH. Orthotopic liver transplantation for subacute hepatic failure following partial treatment of isoniazid-resistant tuberculosis. Transpl Infect Dis 2008 10 : 272 275.
9. Gandhi NR, Moll A, Sturm AW, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006 368 : 1575 1580.
10. Andries K, Verhasselt P, Guillermont J, et al. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science 2005 307 : 223 227.
11. Matsumoto M, Hashizume H, Tomishige T, et al. OPC-67683, a nitro-dihydroimidazooxazole derivative with promising action against tuberculosis in vitro and in mice. PLoS Med 2006 3 : e466.
12. Lamichhane G, Bishai W. Defining the 'survivasome' of Mycobacterium tuberculosis. Nat Med 2007 13 : 280 282.